The AJMC® clinical page includes all the published content across AJMC.com, The American Journal of Managed Care® and Evidence-Based Oncology™ on a variety of specialties, including dermatology, cardiology, oncology, and rheumatology.
June 19th 2025
Telitacicept is a dual-targeting agent that attaches to and blocks the effects of 2 key signaling proteins, B-lymphocyte stimulator and a proliferation-inducing ligand, to treat the B-cell–mediated autoimmune disease, generalized myasthenia gravis.
The Value of a 21-Gene Test in Early-Stage Breast Cancer
July 20th 2016During a health policy session at the annual meeting of the American Society of Clinical Oncology, Steven J. Katz, MD, MPH, discussed the Oncotype DX Breast Cancer Assay, and it's impact on recommendations for chemotherapy in early-stage breast cancer.
Read More
Evidence Lacking on Relation Between IVF and Long-Term Risk of Breast Cancer
July 19th 2016A long-term follow up study among Dutch women who underwent in-vitro fertilization (IVF) treatment in the Netherlands has failed to find an association between the treatment and an increased risk of breast cancer.
Read More
Mismatch Repair Deficiency an Ideal Marker to Initiate Precision Care in CRC
July 19th 2016Research from The University of Texas MD Anderson Cancer Center has tried to fill the knowledge gaps that exist in the treatment of colorectal cancers that harbor mutations in genes involved in DNA mismatch repair.
Read More